Ameriprise Financial Inc. cut its position in shares of Nu Skin Enterprises, Inc. (NYSE:NUS) by 6.7% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 199,601 shares of the company’s stock after selling 14,333 shares during the period. Ameriprise Financial Inc. owned approximately 0.38% of Nu Skin Enterprises worth $12,273,000 at the end of the most recent quarter.

Several other hedge funds have also recently added to or reduced their stakes in NUS. US Bancorp DE lifted its holdings in Nu Skin Enterprises by 3.3% during the 2nd quarter. US Bancorp DE now owns 2,032 shares of the company’s stock valued at $128,000 after buying an additional 65 shares in the last quarter. Migdal Insurance & Financial Holdings Ltd. bought a new stake in Nu Skin Enterprises during the 3rd quarter valued at about $148,000. Texas Yale Capital Corp. bought a new stake in Nu Skin Enterprises during the 2nd quarter valued at about $217,000. Quantbot Technologies LP bought a new stake in Nu Skin Enterprises during the 3rd quarter valued at about $229,000. Finally, Shelton Capital Management bought a new stake in Nu Skin Enterprises during the 2nd quarter valued at about $232,000. 77.53% of the stock is owned by hedge funds and other institutional investors.

Shares of Nu Skin Enterprises, Inc. (NYSE:NUS) opened at $67.44 on Monday. Nu Skin Enterprises, Inc. has a twelve month low of $47.10 and a twelve month high of $68.50. The company has a debt-to-equity ratio of 0.44, a current ratio of 1.78 and a quick ratio of 1.18. The company has a market cap of $3,550.72, a PE ratio of 23.83, a PEG ratio of 2.45 and a beta of 1.57.

Nu Skin Enterprises (NYSE:NUS) last posted its quarterly earnings results on Wednesday, November 1st. The company reported $0.76 EPS for the quarter, meeting the consensus estimate of $0.76. Nu Skin Enterprises had a net margin of 6.97% and a return on equity of 22.38%. The business had revenue of $563.70 million during the quarter, compared to analyst estimates of $562.70 million. During the same quarter in the previous year, the business posted $0.98 EPS. The company’s quarterly revenue was down 6.7% compared to the same quarter last year. sell-side analysts expect that Nu Skin Enterprises, Inc. will post 3.23 earnings per share for the current year.

The firm also recently declared a quarterly dividend, which was paid on Wednesday, December 6th. Stockholders of record on Friday, November 17th were issued a $0.36 dividend. The ex-dividend date of this dividend was Thursday, November 16th. This represents a $1.44 annualized dividend and a dividend yield of 2.14%. Nu Skin Enterprises’s dividend payout ratio is currently 52.75%.

A number of brokerages recently weighed in on NUS. ValuEngine upgraded shares of Nu Skin Enterprises from a “hold” rating to a “buy” rating in a report on Tuesday, November 14th. Zacks Investment Research lowered shares of Nu Skin Enterprises from a “buy” rating to a “hold” rating in a report on Thursday, October 5th. Three research analysts have rated the stock with a sell rating, two have issued a hold rating and four have given a buy rating to the stock. The stock presently has a consensus rating of “Hold” and a consensus price target of $62.00.

In other news, President Ryan S. Napierski sold 11,667 shares of the business’s stock in a transaction dated Wednesday, November 1st. The shares were sold at an average price of $63.84, for a total value of $744,821.28. Following the completion of the sale, the president now owns 71,634 shares in the company, valued at approximately $4,573,114.56. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, President Ryan S. Napierski sold 6,933 shares of the business’s stock in a transaction dated Tuesday, October 10th. The shares were sold at an average price of $64.00, for a total transaction of $443,712.00. The disclosure for this sale can be found here. In the last 90 days, insiders sold 68,600 shares of company stock valued at $4,298,104. Company insiders own 5.20% of the company’s stock.

TRADEMARK VIOLATION WARNING: “Nu Skin Enterprises, Inc. (NUS) Position Lowered by Ameriprise Financial Inc.” was first posted by Watch List News and is the property of of Watch List News. If you are reading this article on another website, it was stolen and reposted in violation of U.S. and international copyright & trademark legislation. The legal version of this article can be accessed at https://www.watchlistnews.com/nu-skin-enterprises-inc-nus-position-lowered-by-ameriprise-financial-inc/1771357.html.

Nu Skin Enterprises Profile

Nu Skin Enterprises, Inc is a direct selling company that develops and distributes personal care products and nutritional supplements, and a range of other products and services. The Company offers anti-aging personal care products and nutritional supplements under its Nu Skin and Pharmanex brands. The Nu Skin brand offers a range of products, including ageLOC Me customized skin care system, ageLOC Spa systems and ageLOC Transformation anti-aging skin care system.

Institutional Ownership by Quarter for Nu Skin Enterprises (NYSE:NUS)

Receive News & Ratings for Nu Skin Enterprises Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises and related companies with MarketBeat.com's FREE daily email newsletter.